Sumitomo Chemical India Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 26 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹26.7K Cr
The company targets growth at least in line with market growth as a base confidence point. Sumitomo Chemical India Limited expects sustainable growth in earnings and profits, with a focus on maintaining or improving EBITDA margins as stated by management.
From Sumitomo Chemical India Ltd's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Price
₹522
Market Cap
₹26.7K Cr
P/E Ratio
46.7
How does Sumitomo Chemical India Ltd rank in Fertilizers & Agrochemicals?
Compare Sumitomo Chemical India Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.
Sumitomo Chemical India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹671 Cr, net profit ₹111 Cr.
Full financials →📊 Revenue & Sales Performance
- →The company targets growth at least in line with market growth as a base confidence point.
- →They aim to grow more than industry growth by launching new, innovative products and driving extensive farmer engagement and demand generation.
- →The strategy has achieved nearly 14x growth over the past 15 years and is expected to continue delivering strong growth.
- →Specialty molecules and new product launches like Meshi, Excalia Max, Lentigo, and Mera 71 have shown promising traction and volume ramp-up despite weather setbacks.
- →New products contribute approximately 8-10% annually and the company expects both specialty and basic segments to grow.
- →Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand.
- →Export growth is dependent on market conditions and regulatory environment, with positive signs in Africa and stabilized pricing.
- →Capacity expansions (e.g., Dahej and Bhavnagar sites) will support growth for the next 10-12 years.
📈 Profitability & Margins
- →Sumitomo Chemical India Limited expects sustainable growth in earnings and profits, with a focus on maintaining or improving EBITDA margins as stated by management.
- →The company aims to maintain EBITDA margins and profit before tax levels without decline, reflecting disciplined pricing and cost control.
- →Recent launches like Meshi, Excalia Max, Lentigo, and Mera 71 show strong traction, supporting revenue growth in agrochemical specialty products.
- →Capital expenditure plans (INR500-600 crores over 5 years at Dahej) aim to enhance manufacturing capacities, potentially boosting revenues from 2028 onwards.
- →The company prioritizes high-margin, specialty molecules over volume-driven growth, emphasizing profitability and sustainable business fundamentals.
- →Improvement in field conditions and normal monsoon expectations support demand recovery in the Rabi season, underpinning near-term growth prospects.
- →Overall, earnings and operating profits are expected to grow in line with industry trends with steady margins and expanding specialty product contributions.
🏗️ Capital Expenditure Plans
- →Potential capex of INR 500-600 crores over next 5 years at Dahej for 6-7 molecules, with capacity utilization extending up to 10-12 years.
- →Initial Dahej capex phase of INR 250-300 crores expected to be approved and implemented during current financial year; revenue generation projected from calendar year 2028 with 18-24 months implementation timeline.
- →Tarapur site has undergone INR 55 crores capex with partial utilization for domestic products; additional INR 10 crores planned for futuristic products.
- →Bhavnagar site capex completed; second phase INR 55 crores capex underway to double capacity by end of 2026.
- →Cash reserves (~INR 2,100 crores) targeted for deployment primarily in Dahej capex and other business opportunities; no plans for special dividends currently.
- →Strategic evaluation ongoing for opportunities beyond agrochemicals.
- →Emphasis on multiproduct, multi-plant expansions with export and domestic mix at Tarapur and Dahej.
💰 Fundraising & Capital Structure
- →Currently, there are no plans to return capital to shareholders via special dividends or other means, indicating no immediate equity fundraising.
- →The company holds significant cash reserves (~INR 2,100 crores) with a strong balance sheet, reducing the immediate need for external fundraising.
- →The focus is on deploying this cash internally for capex projects (e.g., Dahej site expansion) and evaluating other business opportunities, including beyond agrochemicals.
- →No explicit mention of new debt or equity fundraising for near-term capital requirements was made.
- →Discussions are ongoing about various investment opportunities, but no concrete decisions or timelines for new fundraising have been communicated.
📋 Order Book & Pipeline
- →The transcript does not provide explicit details on the current or expected orderbook or pending orders for Sumitomo Chemical India Limited.
- →However, there is mention of strong demand outlook and ongoing customer engagements, particularly with initiatives like "Every Day Farmers Day" to deepen farmer connect and generate demand.
- →The company is focused on scaling up recently launched products and expanding its domestic and export markets, indicating a positive pipeline of orders.
- →Export demand is tied to regulatory approvals and seasonality but is expected to improve, especially in Africa and Latin America.
- →Capacity expansions at Bhavnagar and Dahej sites support anticipated growth in demand.
- →Overall, company management expresses measured optimism about demand and order flow in H2 FY ’26 linked to improved agricultural season conditions.
Key Metrics
Frequently Asked Questions
What were Sumitomo Chemical India Ltd Q2 FY26 results?
The company targets growth at least in line with market growth as a base confidence point. Sumitomo Chemical India Limited expects sustainable growth in earnings and profits, with a focus on maintaining or improving EBITDA margins as stated by management.
What is Sumitomo Chemical India Ltd share price analysis?
Sumitomo Chemical India Ltd currently shows a neutral. The stock trades at a P/E of 46.7 with a market cap of ₹26,687 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sumitomo Chemical India Ltd planning capital expenditure?
Potential capex of INR 500-600 crores over next 5 years at Dahej for 6-7 molecules, with capacity utilization extending up to 10-12 years.
Keep Sumitomo Chemical India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.